View in EDS

Soluble immune-checkpoint factors: a potential immunotherapy biomarker.

Saved in:
Bibliographic Details
Title: Soluble immune-checkpoint factors: a potential immunotherapy biomarker.
Authors: Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, National University of Singapore, Singapore., Cook SL; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA., Khasraw M; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2024 Apr 01; Vol. 134 (7). Date of Electronic Publication: 2024 Apr 01.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38557495
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Soluble immune-checkpoint factors: a potential immunotherapy biomarker.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tan+AC%22">Tan AC</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, National University of Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Cook+SL%22">Cook SL</searchLink>; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Khasraw+M%22">Khasraw M</searchLink>; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2024 Apr 01; Vol. 134 (7). <i>Date of Electronic Publication: </i>2024 Apr 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38557495
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI179352
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Soluble immune-checkpoint factors: a potential immunotherapy biomarker.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tan AC
      – PersonEntity:
          Name:
            NameFull: Cook SL
      – PersonEntity:
          Name:
            NameFull: Khasraw M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2024 Apr 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1558-8238
          Numbering:
            – Type: volume
              Value: 134
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1